babytree

IPO duo slash valuation targets amid weak HK market

One of them, Baytree, could even be worth than less than implied six months ago when Alibaba invested in it during pre-IPO funding.

November 14, 2018

Why investors love China's loss-making health startups

No profit, no problem: a string of Chinese healthcare firms are riding momentum from strong policy support and a vast consumer market all the way to IPOs. But it's not too late to find a good deal.

July 20, 2018